))
Revolutionizing Gene Therapy with Igor Fisch CEO of NewBiologix
Manage episode 423065775 series 3563546
Indhold leveret af Donald Davis, PhD and Don Davis. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af Donald Davis, PhD and Don Davis eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
In this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles.
00:00 Introduction and Welcome
00:15 Igor's Journey into Life Sciences
00:37 The Success of Selexis
00:56 Transition to Gene Therapy
03:32 Challenges in Gene Therapy
03:50 The Importance of Stable Platforms
05:11 The Role of Biotech Startups
05:57 Balancing Science and Business
06:51 Networking at BIO Conference
08:14 Future Vision for New Biologics
09:21 Conclusion and Farewell
102 episoder
Del
